Iproniazid

From Wikipedia, the free encyclopedia

Iproniazid
Systematic (IUPAC) name
N'-propan-2-ylpyridine-4-carbohydrazide
Identifiers
CAS number 54-92-2
ATC code N06AF05
PubChem 3748
Chemical data
Formula C9H13N3O 
Mol. mass 179.219
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status

?

Routes  ?

Iproniazid (iproniazid phosphate, marketed under the names Marsilid®, Iprozid®, Ipronid®, Rivivol®, Propilniazida®) is a monamine oxidase inhibitor (MAOI) that was developed as the first anti-depressant. It was originally intended to treat tuberculosis when it was discovered that patients given iproniazid became "inappropriately happy," subsequently with further research iproniazid was marketed specifically for depression in 1958. It was later replaced by less hepatotoxic drugs.